PubRank

K A Calis

Author PubWeight™ 15.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recombinant interleukin-2: a biological response modifier. Clin Pharm 1991 1.40
2 New hemodialysis membranes and vancomycin clearance. Am J Health Syst Pharm 1995 1.40
3 Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 2000 1.39
4 Symptomatic cardiotoxicity associated with 5-fluorouracil. Pharmacotherapy 1997 1.02
5 Development of a questionnaire for detecting potential adverse drug reactions. Ann Pharmacother 1992 0.93
6 Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy. J Vasc Interv Radiol 2000 0.93
7 Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: review of the clinical literature. The Advisory Panel. J Vasc Interv Radiol 2000 0.84
8 Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome. J Clin Endocrinol Metab 2001 0.84
9 Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia. J Clin Psychopharmacol 2000 0.84
10 Human gene therapy. Clin Pharm 1993 0.79
11 Bosentan and the endothelin system in congestive heart failure. Clin Cardiol 2000 0.79
12 Pimozide-induced depression in men who stutter. J Clin Psychiatry 1997 0.78
13 Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001 0.78
14 Safety reporting in clinical trials. JAMA 2001 0.78
15 Patient-interactive computer system for obtaining medication histories. Am J Hosp Pharm 1993 0.77
16 A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency. Panminerva Med 2014 0.75
17 Effects of metformin on energy intake and satiety in obese children. Diabetes Obes Metab 2015 0.75
18 Sublingual use of benzodiazepines. Drug Intell Clin Pharm 1985 0.75
19 Growth hormone as an adjunct to parenteral nutrition. Am J Hosp Pharm 1994 0.75
20 Zidovudine-associated myopathy. Am J Hosp Pharm 1994 0.75
21 Thrombocytopenia after isolated limb or hepatic perfusions with melphalan: the risk of heparin-induced thrombocytopenia. Ann Surg Oncol 1999 0.75
22 Hypothyroidism associated with aminoglutethimide in patients with prostate cancer. Arch Intern Med 1994 0.75
23 Erythromycin, motilin, and gastroparesis. Clin Pharm 1992 0.75